Abstract
Whether warfarin can bring good outcomes for patients with atrial fibrillation (AF) and chronic kidney disease (CKD) is uncertain. To better answer this question, we performed a meta-analysis to evaluate the safety and efficacy of warfarin in patients with AF and end-stage renal disease (ESRD) and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
